Go a layer deeper on the evolving Medicare Advantage landscape in this briefing designed to provide a quick yet comprehensive, over-view of the critical takeaways and supporting data around the current status of MA.
Key Takeaways:
The rapid growth of MA has left health systems in the financial hot seat, exacerbating pre-existing shifts in payer mix.
The MA “gold rush” has ended. MA is not having the same profitability it once did for payers, intensifying future provider-payer contracting battles.
Provider concerns around MA yield are growing as prior authorization requests and denial rates rise.
Many systems remain committed to a robust MA strategy, despite CFOs reporting MA reimbursements are a drag on revenue.